Metraipolis › archive › dc_0556ee2db05a
Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective,… — Europe PMC PMID:41097761
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41097761
- DOI
- 10.3390/cancers17193235
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T13:55:25.491Z
- SHA-256 of the archived text
e5388c0fbec312165d4701fd48b7abbd7f9a441f2ce70daf8c7b9d102339fa1c- Stable URL of this page
https://metraipolis.com/documento/dc_0556ee2db05a
How to cite
Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective,… — Europe PMC PMID:41097761 — Europe PMC (en), https://europepmc.org/article/MED/41097761 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0556ee2db05a (Metraipolis archive dc_0556ee2db05a, sha256 e5388c0fbec312165d4701fd48b7abbd7f9a441f2ce70daf8c7b9d102339fa1c)
BibTeX
@misc{dc0556ee2db05a,
title = {Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective,… — Europe PMC PMID:41097761},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41097761},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0556ee2db05a; sha256 e5388c0fbec312165d4701fd48b7abbd7f9a441f2ce70daf8c7b9d102339fa1c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41097761. Agents can read the archived copy with the MCP tool read_document.